In Vitro Pancreatic Lipase, Alpha-Amylase and Αlpha-Glucosidase Inhibitory Activities of the Phytochemical Barbaloin
Abstract
In the present study the phytochemical, barbaloin was studied for in-vitro pancreatic lipase, alpha (α)-amylase and alpha (α)-glucosidase inhibitory activities. The aim of this work is to evaluate the inhibitory activities of the phytochemical, barbaloin at different concentrations. Pancreatic lipase is an enzyme that hydrolyzes the lipids obtained from the diet which acts as an important target to treat obesity. The natural medicines that can inhibit pancreatic lipase enzyme and thus decrease absorption of dietary fat in the body gained much attention for the treatment and prevention of obesity. Diabetes mellitus is a metabolic disorder marked by an elevated level of glucose that circulates in the blood plasma. Alpha amylase and alpha glucosidase inhibitors are used to attain control over hyperglycemia in type 2 diabetes mellitus. The present study was designed to screen the novel pancreatic lipase, alpha amylase and alpha glucosidase inhibitors using a phytochemical, barbaloin in order to minimize the toxicity and side effects of the inhibitors which are used at present to treat the disorders like obesity and hyperglycemia. The phytochemical, barbaloin exhibited significant pancreatic lipase, α-amylase and α-glucosidase inhibitory activities with an IC50 value 5.52µg/ml, 8.22µg/ml and 5.81µg/ml respectively and well compared with standard orlistat for pancreatic lipase and acarbose for alpha (α)-amylase and alpha (α)-glucosidase inhibitory activities respectively.
Keywords:
Acarbose, Alpha amylase, Alpha glucosidase, Barbaloin, Pancreatic lipaseDOI
https://doi.org/10.25004/IJPSDR.2023.150106References
Kopelman PG. Obesity is a medical problem. Nature. 2000; 404(4):635–643. doi: 10.1038/35007508
Patel D, Patel K, Tahilyani V. Barbaloin: A concise report of its pharmacological and analytical aspects. Asian Pacific Journal of Tropical Biomedicine. 2012;2(10):835-838. ht tps://doi. org/10.1016/S2221-1691(12)60239-1
Fruh SM. Obesity: Risk factors, complications, and strategies for sustainable long-term weight management. The Journal of the American Association of Nurse Practitioners. 2017; 29(1):3-14. doi: 10.1002/2327-6924.12510.
Heck AM, Yanovski JA, Calis KA. Orlistat: a new lipase inhibitor for the management of obesity. Pharmacotherapy. 2000; 20(3):270-9. doi: 10.1592/phco.20.4.270.34882.
Sapra A, Bhandari P. Diabetes Mellitus: StatPearls Treasure Island (FL). StatPearls Publishing, 2022 .
6. Unai GG, Asier BV, Shifa J, Asier LS, Haziq S, Kepa B, Helena O and César M. Pathophysiology of Type 2 Diabetes Mellitus. International Journal of Molecular Sciences. 2020;20:6275. doi:10.3390/ ijms21176275
Edward JB, Dianna JM, Suvi K, Lorenzo P, Phil R, Pouya S, Hong S. IDF Diabetes Atlas. Edn 10, Berkeley Communications, 2021, pp. 7. www.diabetesatlas.org
Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020; 10(1):107-111. doi: 10.2991/jegh.k.191028.001
Suvi K, Belma M, Pouya S, Paraskevi S. International Diabetes Federation: IDF diabetes atlas. Edn 9, 2019, pp. 4-10.
West IC. Radicals and oxidative stress in diabetes. Diabetic Medicine. 2000;17:171-80. https://doi.org/10.1046/j.1464- 5491.2000.00259.x
Alqahtani AS, Hidayathulla S, Rehman MT, ElGamal AA, Al-Massarani S, Razmovski-NV, Alqahtani MS, El Dib RA, AlAjmi MF. Alpha- Amylase and Alpha-Glucosidase Enzyme Inhibition and Antioxidant Potential of 3-Oxolupenal and Katononic Acid Isolated from Nuxia oppositifolia. Biomolecules. 2019;10(1):61. doi: 10.3390/ biom10010061
Sindhu SN, Vaibhavi K and Anshu M. In vitro studies on alpha amylase and alpha glucosidase inhibitory activities of selected plant extracts. European Journal of Experimental Biology. 2013;3(1):128- 132.
Nagamani M and Swarooparani V. In vitro Studies on the Inhibition of alpha-Amylase and alpha-Glucosidase by Root Extract Fraction of Kyllinga triceps (rottb). International Journal of Pharmaceutical Sciences and Nanotechnology. 2013;6(4):32-36. https://doi. org/10.37285/ijpsn.2020.13.1.7
Kokate CK, Purohit AP, Gokhale SB. Analytical pharmacognosy: phytochemical investigations. Edn 5, Vol 1, Niraliprakashan, India, 1997, pp.55-59.
Tina B and Matthias FM. Medicinal plants traditionally used for treatment of obesity and diabetes mellitus – screening for pancreatic lipase and α-amylase inhibition. Phytotherapy Research. 2016;30(1):260-266. https://doi.org/10.1002/ptr.5525
Margaret ES, Dion GM. Digestion and Absorption: In The Digestive System. Edn 2, New York: Elsevier, 2010
Lunagariya NA, Patel NK, Jagtap SC, Bhutani KK. Inhibitors of pancreatic lipase: state of the art and clinical perspectives. Excli journal. 2014; 13(1):897-921. PMID: 26417311; PMCID: PMC4464291.
Gamal A. Md, Sabrin RM, Ehab SE, Riham SD. Natural anti-obesity agents. Bulletin of Faculty of Pharmacy, Cairo University. 2014;52(2):269-284. https://doi.org/10.1016/j.bfopcu.2014.05.001
Catherine PDG, Breslin PA. Salivary Amylase: Digestion and Metabolic Syndrome. Current Diabetes Reports. 2016;16(10):102. doi: 10.1007/s11892-016-0794-7.
Published
Abstract Display: 369 
PDF Downloads: 412 
